Mirebeau sur Beze, France

Kamel Nasar

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Fournier Laboratories Ireland Limited. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kamel Nasar. Retrieved from https://idiyas.com/inventor/kamel-nasar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kamel Nasar: Innovator in Pharmaceutical Chemistry

Introduction

Kamel Nasar is a notable inventor based in Mirebeau sur Beze, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of quaternary ammonium salts. His work has implications for the development of active substances used in pharmaceutical compositions.

Latest Patents

Nasar holds a patent for a process for preparing quaternary acid and ammonium salts. This innovative process allows for the economical preparation of a choline salt of fenofibric acid in high purity. The method involves a single operation starting from specific chemical compounds, making it a valuable advancement in pharmaceutical manufacturing.

Career Highlights

Throughout his career, Kamel Nasar has worked with prominent companies in the pharmaceutical industry. He has been associated with Fournier Laboratories Ireland Limited and Abbott Laboratories, Ireland, Limited. His experience in these organizations has contributed to his expertise in the field.

Collaborations

Nasar has collaborated with professionals such as Philippe Dellis. These partnerships have likely enhanced his research and development efforts in pharmaceutical chemistry.

Conclusion

Kamel Nasar's contributions to the field of pharmaceutical chemistry, particularly through his patented process, highlight his role as an innovator. His work continues to influence the development of important pharmaceutical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…